A Real-Life Data on the Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir +Ribavirin in Patients With Genotype 1 Chronic Hepatitis C Virus Infection in Serbia
Vojnosanitetski Pregled - Serbia
doi 10.2298/vsp170727186s
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2019
Authors
Publisher
National Library of Serbia